搜尋結果

共 2021 個結果
頁數:1...47 48 49 50 51 52 53 54 55 ...102

恩恤探訪之兩難

... 應新型冠狀病毒肺炎(COVID-19)爆發,公立醫院早在去年1月25日配合政府政策,相應啟動緊急應變級別,實施 ...全文

今日信報副刊文化醫者之言天峯醫生2021年02月17日

華為5G在東盟的發展

... 端和人工智慧技術去為COVID-19病人診斷和治療,減低醫護人員染疫風險。 印尼 印尼定於2035年前發展成熟 ...全文

今日信報時事評論黃伯農2021年02月16日

Contact-tracing app mandatory for govt buildings from March

... confirmed Covid-19 patient. Notification will contain information on where and when the exposure might have occurred. -- Contact us at [email protected] ...More

EJ Insight2021-02-11

Reflections on a plague year

It is probably premature to offer an assessment of the COVID-19 pandemic’s possible consequences, not least because there may well be many more twists and turns to come. And once we defeat the coronav ...More

EJ Insight2021-02-11

大華繼顯:恒指千點區間上落,醫藥新股後有來者

... 肝炎、以至SARS和COVID-19治療。至於為何此藥的用途如此廣泛,據招股文件描述,日达仙是集團合成製備的胸 ...影片

信報視頻宏觀視野2021年02月10日

君實生物(01877) 海外監管公告-業務發展最新情況

... 緊急使用授權用於治療COVID-19的公告(386KB, pdf) ...全文

即時新聞港交所通告2021年02月10日

Sustainability and active ownership in post-COVID-19 era

As COVID-19 provided much cause for pause panic throughout 2020, with markets whipsawing in response to economic recovery, vaccine and immunity hopes in the New Year, the job of analysts assessing lon ...More

EJ Insight2021-02-10

檢疫必要時的權利

... 要求:72小時前去做COVID-19檢測,48小時內上英國政府網站,填妥「乘客定位表格」(Passenger ...全文

今日信報副刊文化酒食浪遊劉群章2021年02月10日

黑客入侵佛州食水廠製造毒水

... ,美國總統拜登據報從COVID-19救助計劃,撥出100億美元專項資金,用於改善當地網絡安全。   ...全文

今日信報財經新聞StartupBeat 創科鬥室2021年02月10日

China economy: Four key investment questions for Year of the Ox

This lunar new year, China has much to celebrate – including resilient economic growth, widespread success at suppressing Covid-19 and a steady transformation into an advanced economy. The “Ox” may be ...More

EJ Insight2021-02-09

高危病人應否接種疫苗

差不多每一位覆診的心臟病人也會問同一問題:應否接種新冠病毒(COVID-19)疫苗及應該選擇接種哪一種疫苗? ...全文

今日信報副刊文化心臟科馮永康醫生2021年02月09日

克服人類發展的氣候挑戰

... 的增長與發展。 或許COVID-19疫情是當前發展模式給本地生態系統造成巨大壓力的最清晰例子。一種小小的病原體 ...全文

今日信報時事評論Kanni Wignaraja2021年02月09日

Overcoming the climate challenge

... ed by the COVID-19 pandemic. A tiny pathogen has laid bare massive vulnerabilities and gross inequalities in even the strongest and most prosperous societies, with economic and social imbalances reinf ...More

EJ Insight2021-02-05

中藥防治「新冠」是草還是寶之二 未病先防 有病防變

... ase 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang a ...全文

今日信報副刊文化自講自治黃譚智媛2021年02月05日

Prevent the next food crisis now

The toxic cocktail of climate change, conflict, and COVID-19 is making itself felt most intensely in the world’s poorest and most vulnerable countries. As a result, a record 235 million people worldwi ...More

EJ Insight2021-02-04

立即阻止下一場糧食危機

氣候變化、衝突和COVID-19已經混成一杯毒酒,對全世界最貧窮最脆弱的國家毒害最深。在2021年,全世界有破 ...全文

今日信報時事評論Mark Lowcock, Axel van Trotsenburg2021年02月04日

The unwanted ambush lockdown

... mandatory Covid-19 test. Well, no one is sure if they were a virus carrier but then most people would find it disturbing, as witnessed on television. Imagine if you were one of the 50 people stuck in ...More

EJ Insight2021-02-03

How cloud technology can transform the financial services sector

... ever turn Covid-19 now takes, the financial services sector’s upgrade is well underway. Its newfound focus on technology points to an appetite for innovation that is likely to extend well beyond the c ...More

EJ Insight2021-02-03

Vaccination is not enough

In the next stage of the fight against COVID-19, can we rely on vaccines alone? Although vaccination in the United States and some other countries is beginning to pick up pace, in most countries it ha ...More

EJ Insight2021-02-03

Biden goes big

... lves when COVID-19 is brought under control. The fact that COVID-19 is a pandemic – global in scope – makes matters worse. While the best available data suggests that many developing countries and eme ...More

EJ Insight2021-02-02

頁數:1...47 48 49 50 51 52 53 54 55 ...102

信報簡介 | 服務條款 | 私隱條款 | 免責聲明 | 廣告查詢 | 加入信報 | 聯絡信報

股票及指數資料由財經智珠網有限公司提供。期貨指數資料由天滙財經有限公司提供。外滙及黃金報價由路透社提供。

本網站的內容概不構成任何投資意見,本網站內容亦並非就任何個別投資者的特定投資目標、財務狀況及個別需要而編製。投資者不應只按本網站內容進行投資。在作出任何投資決定前,投資者應考慮產品的特點、其本身的投資目標、可承受的風險程度及其他因素,並適當地尋求獨立的財務及專業意見。本網站及其資訊供應商竭力提供準確而可靠的資料,但並不保證資料絕對無誤,資料如有錯漏而令閣下蒙受損失,本公司概不負責。